A detailed history of Hillman Capital Management, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Hillman Capital Management, Inc. holds 160,445 shares of BMY stock, worth $9.27 Million. This represents 2.93% of its overall portfolio holdings.

Number of Shares
160,445
Previous 160,529 0.05%
Holding current value
$9.27 Million
Previous $6.67 Million 24.56%
% of portfolio
2.93%
Previous 2.42%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$39.66 - $51.75 $3,331 - $4,347
-84 Reduced 0.05%
160,445 $8.3 Million
Q2 2024

Aug 14, 2024

BUY
$40.25 - $52.99 $6.46 Million - $8.51 Million
160,529 New
160,529 $6.67 Million
Q2 2022

Aug 15, 2022

SELL
$72.62 - $79.98 $9.86 Million - $10.9 Million
-135,731 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$61.48 - $73.72 $110,295 - $132,253
1,794 Added 1.34%
135,731 $9.91 Million
Q4 2021

Feb 14, 2022

SELL
$53.63 - $62.52 $233,344 - $272,024
-4,351 Reduced 3.15%
133,937 $8.35 Million
Q3 2021

Nov 15, 2021

BUY
$59.17 - $69.31 $1.2 Million - $1.4 Million
20,231 Added 17.14%
138,288 $8.18 Million
Q2 2021

Aug 16, 2021

BUY
$61.91 - $67.42 $58,814 - $64,049
950 Added 0.81%
118,057 $7.89 Million
Q1 2021

May 14, 2021

BUY
$59.34 - $66.74 $1.97 Million - $2.21 Million
33,117 Added 39.43%
117,107 $7.39 Million
Q4 2020

Feb 12, 2021

BUY
$57.74 - $65.43 $18,245 - $20,675
316 Added 0.38%
83,990 $5.21 Million
Q3 2020

Nov 09, 2020

SELL
$57.43 - $63.64 $20,215 - $22,401
-352 Reduced 0.42%
83,674 $5.05 Million
Q2 2020

Aug 04, 2020

SELL
$54.82 - $64.09 $49,557 - $57,937
-904 Reduced 1.06%
84,026 $4.94 Million
Q1 2020

Apr 29, 2020

SELL
$46.4 - $67.43 $79,390 - $115,372
-1,711 Reduced 1.97%
84,930 $4.73 Million
Q4 2019

Feb 14, 2020

BUY
$49.21 - $64.19 $4.26 Million - $5.56 Million
86,641 New
86,641 $5.56 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Hillman Capital Management, Inc. Portfolio

Follow Hillman Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hillman Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hillman Capital Management, Inc. with notifications on news.